Alli AA, Desai D, Elshika A, Conrad M, Proneth B, Clapp W, et al
Hepatic cytochrome P450 enzyme activity and renal clearance efficiency both decline with age, which could theoretically extend the dihexa half life in older subjects, but specific pharmacokinetic data stratified by age are not published for dihexa
doi: 10.1155/2017/8416763 171 AcevesCAnguianoBDelgadoG
Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor
Step 1: Choose a High-Bioavailability Supplement Look for a liquid liposomal format